BIRAC Early Translation Accelerator (ETA), aims towards catalysing transformation of young academic discoveries (publications/patents) with possible commercial and societal impact into economically viable ventures and technologies.

Under the BIRAC’s ETA Program, the incubator is responsible for facilitating translation of innovative ideas into biotech products and attracts industry to take validated technologies solving unmet needs (originated from academic labs) forward in terms of development.

These selected technologies are validated in the clinical settings with funding support from BIRAC and the Industry Partner. The incubator manages the funding and the execution of the project.YTI with his capabilities and expertise in pre-clinical validation, clinical manufacturing and clinical trials ensures to provide a nurturing ecosystem for successful execution of the program.